130 related articles for article (PubMed ID: 11030087)
1. Carbonic anhydrase activators: synthesis of high affinity isozymes I, II and IV activators, derivatives of 4-(arylsulfonylureido-amino acyl)ethyl-1H-imidazole.
Supuran CT; Scozzafava A
J Enzyme Inhib; 2000; 15(5):471-86. PubMed ID: 11030087
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase activators: synthesis of high affinity isozymes I, II and IV activators, derivatives of 4-(4-tosylureido-amino acyl)ethyl-1H-imidazole (histamine derivatives).
Scozzafava A; Iorga B; Supuran CT
J Enzyme Inhib; 2000; 15(2):139-61. PubMed ID: 10938540
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase activators. Part 24. High affinity isozymes I, II and IV activators, derivatives of 4-(4-chlorophenylsulfonylureido-amino acyl)ethyl-1H-imidazole.
Scozzafava A; Supuran CT
Eur J Pharm Sci; 2000 Mar; 10(1):29-41. PubMed ID: 10699381
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase activators: high affinity isozymes I, II, and IV activators, incorporating a beta-alanyl-histidine scaffold.
Scozzafava A; Supuran CT
J Med Chem; 2002 Jan; 45(2):284-91. PubMed ID: 11784133
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase activators - part 21. Novel activators of isozymes I, II and IV incorporating carboxamido and ureido histamine moieties.
Scozzafava A; Supuran CT
Eur J Med Chem; 2000 Jan; 35(1):31-9. PubMed ID: 10733601
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase activators: amino acyl/dipeptidyl histamine derivatives bind with high affinity to isozymes I, II and IV and act as efficient activators.
Supuran CT; Scozzafava A
Bioorg Med Chem; 1999 Dec; 7(12):2915-23. PubMed ID: 10658596
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase activators: design of high affinity isozymes I, II, and IV activators, incorporating tri-/tetrasubstituted-pyridinium-azole moieties.
Ilies M; Banciu MD; Ilies MA; Scozzafava A; Caproiu MT; Supuran CT
J Med Chem; 2002 Jan; 45(2):504-10. PubMed ID: 11784154
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators.
Temperini C; Scozzafava A; Puccetti L; Supuran CT
Bioorg Med Chem Lett; 2005 Dec; 15(23):5136-41. PubMed ID: 16214338
[TBL] [Abstract][Full Text] [Related]
9. α-Carbonic anhydrases are strongly activated by spinaceamine derivatives.
Akocak S; Lolak N; Bua S; Nocentini A; Karakoc G; Supuran CT
Bioorg Med Chem; 2019 Mar; 27(5):800-804. PubMed ID: 30683554
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme.
Temperini C; Scozzafava A; Vullo D; Supuran CT
Chemistry; 2006 Sep; 12(27):7057-66. PubMed ID: 16807956
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design.
Temperini C; Scozzafava A; Vullo D; Supuran CT
J Med Chem; 2006 May; 49(10):3019-27. PubMed ID: 16686544
[TBL] [Abstract][Full Text] [Related]
12. Novel carbonic anhydrase isozymes I, II and IV activators incorporating sulfonyl-histamino moieties.
Briganti F; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 1999 Jul; 9(14):2043-8. PubMed ID: 10450978
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of histamine Schiff bases as carbonic anhydrase I, II, IV, VII, and IX activators.
Akocak S; Lolak N; Vullo D; Durgun M; Supuran CT
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1305-1312. PubMed ID: 29072105
[TBL] [Abstract][Full Text] [Related]
14. Ethylene bis-imidazoles are highly potent and selective activators for isozymes VA and VII of carbonic anhydrase, with a potential nootropic effect.
Draghici B; Vullo D; Akocak S; Walker EA; Supuran CT; Ilies MA
Chem Commun (Camb); 2014 Jun; 50(45):5980-3. PubMed ID: 24763985
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.
Scozzafava A; Supuran CT
J Med Chem; 2000 Oct; 43(20):3677-87. PubMed ID: 11020282
[TBL] [Abstract][Full Text] [Related]
16. New Histamine-Related Five-Membered N-Heterocycle Derivatives as Carbonic Anhydrase I Activators.
Chiaramonte N; Gabellini A; Angeli A; Bartolucci G; Braconi L; Dei S; Teodori E; Supuran CT; Romanelli MN
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056859
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase activity modulators: synthesis of inhibitors and activators incorporating 2-substituted-thiazol-4-yl-methyl scaffolds.
Scozzafava A; Saramet I; Banciu MD; Supuran CT
J Enzyme Inhib; 2001 Oct; 16(4):351-8. PubMed ID: 11916140
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase activators: kinetic and X-ray crystallographic study for the interaction of D- and L-tryptophan with the mammalian isoforms I-XIV.
Temperini C; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2008 Sep; 16(18):8373-8. PubMed ID: 18774300
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV.
Temperini C; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT
Bioorg Med Chem Lett; 2007 Feb; 17(3):628-35. PubMed ID: 17127057
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
